Spectrum Pharmaceuticals Inc expected to post a loss of 28 cents a share - Earnings Preview

Spectrum Pharmaceuticals

03/11/2021 10:10

* Spectrum Pharmaceuticals Inc  SPPI.OQ   SPPI.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 3 (estimated). 
* The Henderson, Nevada-based company is expected to report
revenue of $516.67 thousand, according to the mean estimate from
6 analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Spectrum
Pharmaceuticals Inc is for a loss of 28 cents per share. For the
same quarter last year, the company reported a loss of 37 cents
per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $6​, about 65.7% above​ its last closing
price of $2.06. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   -0.25       -0.25      -0.32     Missed  -25.5
 Mar. 312021   -0.30       -0.31      -0.25     Beat    20.6
 Dec. 312020               -0.29      -0.29     Met     0​
 Sep. 302020   -0.35       -0.35      -0.37     Missed  -5.7
 ​​Jun.        -0.29       -0.32      -0.28     Beat    11.4
 302020                                                 
 Mar. 312020   -0.34       -0.35      -0.36     Missed  -4​
 Dec. 312019   -0.33       -0.33      -0.35     Missed  -7.4
 Sep. 302019   -0.36       -0.41      -0.23     Beat    44.6
 This summary was machine generated November 3 at 10:10 GMT.  All
figures in US dollars unless otherwise stated